Therapeutic effect of flax-based diets on fatty liver in aged laying hens

about

Therapeutic effect of flax-based diets on fatty liver in aged laying hens

Item

http://www.wikidata.org/entity/Q39796475

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Therapeutic effect of flax-based diets on fatty liver in aged laying hens

@en

Therapeutic effect of flax-based diets on fatty liver in aged laying hens.

@nl

type

Item

label

Therapeutic effect of flax-based diets on fatty liver in aged laying hens

@en

Therapeutic effect of flax-based diets on fatty liver in aged laying hens.

@nl

prefLabel

Therapeutic effect of flax-based diets on fatty liver in aged laying hens

@en

Therapeutic effect of flax-based diets on fatty liver in aged laying hens.

@nl

P1476

Therapeutic effect of flax-based diets on fatty liver in aged laying hens

@en

P2093

C Small

http://www.w3.org/2001/XMLSchema#string

D B Hales

http://www.w3.org/2001/XMLSchema#string

J Cain

http://www.w3.org/2001/XMLSchema#string

J E Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

The life of lipid droplets

Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.

[Nutritional value and functional properties of flaxseed].

Flaxseed: a potential source of food, feed and fiber.

Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol.

The influence of omega-3 polyunsaturated fatty acids feeding on composition of fatty acids in fatty tissues and eggs of laying hens.

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject.

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.

P304

2624-2632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3382/PS/PEW160

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27143762

http://www.w3.org/2001/XMLSchema#string

P932

5049100

http://www.w3.org/2001/XMLSchema#string